ReviewFrontiers in pharmacology2025

Therapeutic strategies for KRAS G12C-mutant non-small cell lung cancer: from bench to bedside and beyond.

Renjie Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.